Abstract
The insulin-like growth factors (IGFs), IGF-I and IGFin the central nervous system in both rodents [3, 11, 16] and II, are mitogenic polypeptides with structural homology to humans [1, 7] . The distribution of IGF-II receptors has been insulin. Two major types of receptors recognize the IGFs investigated in rodent brain [11, 16, 20] . However, there is and mediate their physiological effects: IGF-I and IGF-II only one report dealing with the presence of IGF-II receptors [6, 8, 9] . The IGF-I receptor is a heterotetrameric binding sites in brain homogenates from a single individual glycoprotein composed of two a and two b subunits linked [19] . Here we present the first autoradiographic study in by disulfide bounds [6] . The IGF-II receptor is a monohuman brain. meric receptor with a striking extracellular domain made Brain tissue was obtained at autopsy from six patients up almost exclusively of 15 cysteine-based repeats, and is (three females and three males), aged 65-78 years, who identical to the cation-independent mannose-6-phosphate had died without evidence of neurologic or psychiatric receptor [14, 18] . In fact, these receptors display two disease. Slices of hemispheric white matter containing distinctive binding sites: one for IGF-II and another for chronic plaques with dense astrogliosis, identified by glial mannose-6-phosphate containing glycoproteins, which are fibrillary acidic protein (GFAP) immunoperoxidase stainmainly lysosomal enzymes that are endocytosed into ing, were obtained from four patients with multiple endosomes. IGF-I receptors have been studied extensively sclerosis (three females and one male; aged 59-78 years). Post-mortem delay ranged between 4 and 12 h. Tissue blocks of 0.5-cm thick were frozen rapidly by immersion in isopenthane-dry-ice or liquid nitrogen, and stored at [ I]IGF-II. After incubation, the sections were washed in ice-cold buffer to remove unbound ligand, wiped from the slides with Whatman GF / B glass fiber filters, and radioactivity was determined in a gamma-counter. Binding isotherms were analyzed by non-linear least-square curve [ I]standards (Amersham), and apposed to [ H]Ultrofilm identified. These proteins can bind both IGF-I and IGF-II, (Amersham) for 4 days and analyzed as described previand regulate their access to the IGF receptors [2, 5, 6, 9] . By ously [7] . The regions of interest were sampled and mean using immunocytochemistry on unwashed slices of frontal optical densities determined, and converted into fmol / mg cortex we were able to identify IGFBPs 1, 2, 3, 5 and 6 on protein, based on the experimentally determined relation neuronal cell bodies. However, after preincubating the between polymer and brain paste standards (kindly proslices for 15 min at 208C in the same buffer used by vided by Amersham, UK). autoradiographic experiments, IGFBPs were no longer For immunocytochemistry sections were fixed in 3% detectable in the slices (Fig. 2) . Thus, IGFBPs were paraformaldehyde in 0.01 M phosphate buffered saline removed from the tissue slices during the preincubation (PBS) for 15 min at room temperature and three times procedure, indicating that in the experimental conditions detected in substantia nigra and periaquaductal gray. Low whereas IGF-I receptors predominate in the molecular cell binding was also observed in the red nucleus. In the pons layer [7] . moderate levels of IGF-II receptors were associated with
The finding that discrete neuronal regions contain higher the pontine nuclei. Moderate levels of IGF-II receptors levels of IGF-II receptors may suggest a more specialized were also observed in the pallidium, amygdala, and role of IGF-II as trophic / survival factor or perhaps as thalamus. We found no IGF-II receptors in the white neuromodulator for well-defined neuronal systems. The matter. In many brain areas, such as the striatum, cerebral role of the IGF-II receptors in the different neuronal cortex, and hippocampus, the distribution pattern of IGF-II regions is not well understood. In vitro, IGF-II mimics the receptors is comparable to that of IGF-I receptors [7] . The mitogenic actions of IGF-I, through stimulation of IGF-I most striking difference is that in the cerebellar cortex receptors [6, 15] . In human brain IGF-I has a ten times highest labeling was observed in the granular cell layer, higher affinity than IGF-II for the IGF-I receptor [7] . On the other hand, we found in this study that IGF-II was ten Chronic plaques of multiple sclerosis were identified by 125 times more potent than IGF-I in displacing [ I]IGF-II. myelin staining (Fig. 4) . The plaques contained a dense These findings indicate that in human brain, under physioatrogliosis as visualized by GFAP immunochemistry (not logical conditions, IGF-I preferentially interacts with IGF-I shown). Similar to normal appearing white matter, we 125 receptors, and IGF-II with IGF-II receptors. In vitro could not detect specific binding of [ I]IGF-II to IGF-II observations suggest that IGF-II receptors may function in receptors in any of these plaques. IGF-II receptor condiverse biologic processes. IGF-II may act as a modulator centrations in cerebral cortex of MS patients (3163 fmol / for the trafficking of mannose-6-phosphate bearing mg protein) were not significantly different from those in lysosomal enzymes into the cell [11, 14, 18] . Binding of controls (2967 fmol / mg protein; Mann-Whitney test). It IGF-II to its receptor may also activate a signaling has previously been reported that IGF-I receptors are mechanism through interaction with a GTP-binding protein present in white matter and astrogliotic plaques from [5, 14] , the physiological role of which is not yet underpatients with multiple sclerosis, which is consistent with a stood. Konishi et al. [13] found that IGF-II enhanced well-recognized role of IGF-I in oligodendrocyte survival, choline acetyltransferase activity in a dose-dependent myelination, and stimulation of astrocytes [21] . The abmanner in cultures of embryonic mouse septal neurons.
sence of IGF-II receptors in the astrogliotic plaques Part of this effect was related to a specific interaction with indicates that IGF-II receptors are not involved in the IGF-II receptors, and suggested a role of IGF-II receptors mechanisms of astrogliosis. in the differentiation of cholinergic neurons. Further evidence for a role of IGF-II in the cholinergic neurotransmitter system was the observation that IGF-II poten- to microscope slide-mounted sections at the level of (A) frontal cortex (co) and white matter (wm), (B) caudate nucleus (cd) / putamen (put)5neostriatum and nucleus accumbens (acc), (C) claustrum (clau), pallidium (pal) and putamen (put), (D) amygdala (am), (E) hippocampus: dentate gyrus (dg) / pyramidal cell layer (pc), and para-hypocampal gyrus (pg), and (F) midbrain: substantia nigra (sn) / colliculus superior (cs) / red nucleus (rn) and periaquaductal gray (pg). Bar51 cm. 
